title: Rechallenging 5-Fluorouracil in a Patient With Capecitabine-Induced Ventricular Fibrillation.
authors: Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC. Electronic address: laisueyi@gmail.com.
authors: Sueyi
authors: S
authors: Lai
authors: Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.
authors: John L
authors: JL
authors: Marshall
authors: Division of Cardiology, Department of Medicine, Georgetown University Hospital, Washington, DC.
authors: Richard L
authors: RL
authors: Morrissey
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000069287:Capecitabine / Q000008:administration & dosage / Q000009:adverse effects*; D017147:Defibrillators, Implantable; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006323:Heart Arrest / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000517:prevention & control
chemical_list: D000964:Antimetabolites, Antineoplastic; D000069287:Capecitabine; D005472:Fluorouracil
keywords: Cardiotoxicity; Colorectal cancer; FLOX; Vasospasm